510(k) Report

510(k) · Cleared

Cleared

Brainsway Deep TMS System

K200957510(k) TraditionalCleared Aug 21, 2020134-day reviewClass II21 CFR 882.5802

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Brainsway, Ltd. · QMD Transcranial Magnetic Stimulation System For Smoking Cessation

Cleared on Aug 21, 2020 as substantially equivalent to DEN170078 (Brainways, Ltd., 2018) after a 134-day review. Its family tree reaches back 1 generation to 2018. 1 later device descends from it.

Decided
Aug 21, 2020
Review
134 days
Class
Class II
Product code
QMD
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to DEN170078 (2018). 1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2021: 1 descendant clearedDEN170078 · Brainsway Deep Transcranial Magnetic Stimulation (DTMS) System · Brainways, Ltd. · 2018201620182020202220242026
Descendants, by generation 1 generation forward: 1 descendant DEN170078 · Brainsway Deep Transcranial Magnetic Stimulation (DTMS) System · Brainways, Ltd. · 20180
  1. Root · 1 generation backDEN170078 Brainsway Deep Transcranial Magnetic Stimulation (DTMS) SystemBrainways, Ltd. · 2018
  2. This deviceK200957 Brainsway Deep TMS SystemBrainsway, Ltd. · 2020
  3. Descendant · cites it directly · 0 of its ownK203616 Brainsway Deep (DTMS) SystemBrainsway, Ltd. · 2021

Most influential descendants

Showing 1 of 1 · See all
  • K203616Brainsway Deep (DTMS) SystemBrainsway, Ltd. · 2021 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1DEN170078Brainsway Deep Transcranial Magnetic Stimulation (DTMS) SystemBrainways, Ltd.2018—
0 (this device)K200957Brainsway Deep TMS SystemBrainsway, Ltd.2020—
+1K203616Brainsway Deep (DTMS) SystemBrainsway, Ltd.2021—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202110
FIG. 1 — Lineage of K200957, 2018–2021Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QMD? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QMD device

  1. #1 K203616 Brainsway Deep (DTMS) Systemscore 1.5 · 2 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*DEN170078Brainsway Deep Transcranial Magnetic Stimulation (DTMS) System
Summary page 5
…following predicate devices: Predicate Manufacturer De Novo No. Brainsway Ltd. Brainsway Deep TMS System DEN170078 Device Description: The Brainsway Deep TMS System enables direct non-invasive activation of deep brain structure…
Brainways, Ltd.2018—

Also cleared against DEN170078: 2 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K203616Brainsway Deep (DTMS) SystemBrainsway, Ltd.20210

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K203616 (Brainsway, Ltd., 2021) has gone furthest, with 0 descendants of its own.
  • 2 other devices also cite its predicate DEN170078.

How does its category compare?

All QMD devices

QMD Transcranial Magnetic Stimulation System For Smoking Cessation: FDA decisions, review times, recalls and adverse event reports over 20 years. 2020, this device’s year, is highlighted.

FDA decisions per year · QMD

1in 2021

2020: 12021: 1
2007high 1 (2020) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QMD

Too few QMD 510(k)s in any year since 2007 to give a median.

Recalls per year · QMD

No recall names QMD since 2007.

Adverse event reports per year · QMD

No MAUDE report names QMD since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20201—00
20211—00
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

The Brainsway Deep Transcranial Magnetic Stimulation System is indicated to be used as an aid in short-term smoking cessation for adults.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K200957: Brainsway Deep TMS System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K200957

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026